A 26-year-old male, the index patient, presented with persecutory delusions and suicidal behavior. He had 10 paternal male relatives in two prior generations. Five of them died by violent suicide and one, of the five, also committed a double homicide. The index patient was found to be hypocholesterolemic due to being heterozygous for a novel mutation of apolipoprotein B (apoB-29.4). His mother and paternal grandmother were normocholesterolemic, whereas a surviving paternal uncle was hypocholesterolemic and heterozygous for the apoB-29.4 mutation. This indicated that the index patient's father and paternal grandfather, both of which died by violent suicide, were obligate heterozygotes for the apoB-29.4 mutation and that the index patient inherited the mutation from his paternal grandfather. The odds ratio for the association between hypocholesterolemia and violent behavior in this family, where cholesterol status was known, was 16.9 (95% confidence interval 1.1-239.3). Therefore, our results support an inheritable relationship between violent behavior and hypocholesterolemia.
Introduction
Violence is a substantial source of morbidity and is the leading cause of death in persons younger than 44 years of age. 1 Interest in cholesterol as a biological marker of violent behavior has arisen following consistent evidence from observational studies (including cohort, case-control and cross-sectional studies), suggesting that hypocholesterolemia associates with violent behavior, particularly violent suicide, in individuals. [2] [3] [4] [5] [6] [7] [8] Violent suicide, such as hanging, use of a firearm, laceration and jumping from a height, has been suggested to be a behavioral marker of lifetime aggression. 9 Evidence from twin and adoption studies and from families with a history of suicide suggests that there is also a genetic component to suicidal behavior. 10, 11 Apolipoprotein (apo)B is a large amphipathic glycoprotein that plays a central role in human lipoprotein metabolism. Full-length apoB (apoB-100) is synthesized in the liver and is the major protein component of very low-density lipoprotein (VLDL) and low-density lipoprotein (LDL). The important determinants of VLDL assembly and secretion are apoB length, 12 an adequate supply of lipid 13 and the presence of sequences in the ba1 domain of apoB that interact with microsomal triglyceride transfer protein (MTP). 14 Familial hypobetalipoproteinemia (FHBL) (OMIM 107730) is a codominant disorder of lipoprotein metabolism characterized by low levels ( < 5th percentile for age and sex) of LDL-cholesterol and apoB. 15, 16 Over 50 mutations in the APOB gene, on chromosome 2, have been described to date, which either affect splicing or result in the production of truncated apoB isoforms. 17 Immunoblotting is the primary means for detecting truncated apoB isoforms in plasma. However, truncations shorter than apoB-31, such as the novel apoB-29.4 mutation found in this paternal family, are not detectable in plasma. 17 Therefore, termination mutations in the first 30% of APOB sequence can only be discovered by genetic analysis.
Here we describe a family with marked hypocholesterolemia and low plasma vitamin E due to FHBL, where five male relatives died by violent suicide, one of whom committed a double homicide.
Materials and methods
Blood samples were taken by venesection of the index patient and family members and cholesterol and triglyceride assays were performed on a Roche Modular analyzer (Roche Diagnostics, Auckland, New Zealand). Informed consent was obtained from family members for genetic testing. LDL-cholesterol was calculated using the Friedewald formula. Apo measurements were performed on a Beckman Immage nephelometer (Beckman Instruments, Fullerton, CA, USA). Vitamin A and E were measured by high-pressure liquid chromatography (Table 1) Liver enzymes were measured enzymatically on an Aeroset/c8000 analyzer (Abbott Labs, Abbott Park, IL, USA).
Plasma was screened for truncated apoB variants by immunoblotting of blood samples separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis using the Mini-Protean II cell system (BioRad, Richmond, CA, USA). The separated proteins were transferred to nitrocellulose membrane and incubated with rabbit anti-human polyclonal ApoB antibody (DAKO, Carpinteria, CA, USA) followed by goat anti-rabbit horseradish peroxidase-conjugated antibody (Amersham Biosciences, Auckland, New Zealand). Detection was performed using an Enhanced Chemiluminescence Western Blotting Analysis System (Amersham Biosciences).
The entire coding region and exon/intron boundaries of the subject's APOB and MTP genes were amplified by PCR (primer sequences are available upon request). Each reaction contained 100 ng genomic DNA, 5 pmol each of forward and reverse primer, 2 mM MgCl 2 , 1 Â reaction buffer containing dNTPs and 1 U Taq DNA polymerase (Roche, Basel, Switzerland) in a total volume of 25 ml. The following cycling conditions were used: one cycle of 951C for 5 min, 35 cycles of 951C for 30 s, 581C for 30 s and 721C for 45 s, and a final cycle of 721C for 2 min. The PCR products were used as templates for DNA sequencing using the dye-terminator method on an ABI 3100 DNA sequencer (Applied Biosystems, Foster City, CA, USA). To identify mutations, results were aligned with known MTP and APOB genomic sequence. APOE genotyping was performed by PCR amplification and digestion with HhaI.
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The odds ratio (Peto) was calculated for an unmatched case-control study, using the null hypothesis, to provide an estimate of the significance of the association between violent behavior and hypocholesterolemia. 19 Violent behavior was defined as suicide, attempted suicide and homicide. Individuals in whom cholesterol status was known or could be deduced were I:2, I:3, I:4, II:1, II:3, II:9, II:10 and III:14.
Results
The index patient, a male aged 26 years, and the members of his paternal and maternal families were New Zealand born Europeans.
The index patient was investigated on his second admission to an acute psychiatric in-patient unit. His persecutory delusions had recurred and he believed that Nazis were poisoning his food and putting his private information on the Internet. At the time of admission, he lived independently but had left university and was unemployed. A diagnosis of Schizoaffective Disorder, DSM-IV-TR (295.70), 20 was confirmed by clinical review by a qualified psychiatrist. The index patient also met criteria for co-morbid diagnoses of Cannabis Dependence in Partial Remission, DSM-IV-TR (304.30) and Social Phobia DSM-IV-TR (300.23). 20 He had made one suicide attempt, by overdose of medication, at the age of 18 years.
The index patient was physically well and routine clinical neurological examination was unremarkable.
The index patient responded to a trial of clozapine. His previous medication regime included olanzapine and citalopram.
On investigation, the index patient had low plasma LDL-cholesterol, vitamin E and apoB (hypobetalipoproteinemia) concentrations (Table 1 ) and about 17% of his erythrocytes were acanthocytic (Figure 1 ). His serum liver enzymes (alanine aminotransferase, aspartate aminotransferase and gamma glutamyltransferase) were within the reference interval. Immunoblotting of his plasma indicated a single apoB-100 band. The APOB, APOE and MTP genes were examined and a C to A transversion at nucleotide 4089 of the APOB gene was identified (Figure 2 ). This novel mutation changed the TAC codon to TAA resulting in premature termination of the protein (APOB Tyr1336Ter) and a truncated apoB variant, 29.4% of the full-length (apoB-100) protein. The MTP gene was free of mutation and his APOE genotype was E3/3. One hundred chromosomes were genotyped for the apoB-29.4 mutation in APOB exon 25 by dyeterminator DNA sequencing. All alleles were wild type, excluding the variant as a polymorphism.
A surviving paternal uncle ( Figure 3 , II:1) and the index patient's mother (II:10) provided family history. Five paternal male relatives of the index patient, in two immediate prior generations, committed violent suicide using firearms (I:1, I:3, II:4, II:6, II:9). One paternal uncle (II:4) also perpetrated a double homicide, using a firearm, before committing suicide. This occurred shortly after his first admission to a psychiatric hospital, for a major depressive episode, at the age of 19 years. The male relatives of the third paternal generation were alive and were between the ages of 8 and 26 years (n = 7) (Figure 3, III) .
The uncle (II:1) denied ever being treated for a psychiatric illness or having symptoms that indicated past episodes of psychosis, mania or depression. He also denied ever having suicidal or homicidal ideas or being involved in significant violence. However, the uncle's presentation and history indicated a hyperthymic personality. He had three occupations, was a member of three voluntary organizations and two sports teams and required only 5 h sleep per night. On examination, he exhibited pressure of speech. He was physically well and investigations showed he had low plasma LDL-cholesterol, vitamin E and apoB concentrations and that he carried the apoB-29.4 mutation ( Table 1) . He reported that no paternal family member, other than uncle II:4, had ever been treated for a psychiatric illness.
The index patient's mother (II:10) denied ever being treated for a psychiatric illness or having symptoms that indicated past episodes of psychosis, mania or depression. She was physically well, normocholesterolemic and had a normal apoB plasma concentration (Table 1) . Her serum liver enzymes were normal and her APOE genotype was E3/3. She reported that no family member in the immediate two prior maternal generations to the index patient had committed suicide or homicide. She said that one female maternal family member was diagnosed with obsessive compulsive disorder and two other female maternal family members were diagnosed with major depressive disorder.
Incidental routine lipid investigation of the index patient's paternal grandmother (I:4), great uncle (I:2) and another uncle (II:3) showed their LDL-cholesterol and total cholesterol were within the reference interval. Therefore, these family members were not carriers of the apoB-29.4 mutation.
Discussion
The index patient's APOE genotype was E3/E3 and the MTP gene was free of mutation indicating that the apoB-29.4 mutation was the sole cause of the index patient's hypocholesterolemia. 21, 22 The index patient's uncle (II:1) carried the apoB-29.4 mutation and was hypocholesterolemic, whereas the index patient's mother (II:10) was normocholesterolemic and did not carry the apoB-29.4 mutation, which showed that the index patient inherited the hypobetalipoproteinemia from his paternal grandfather (I:3).
Heterozygous FHBL has been estimated to affect 1 in 3000 individuals. 21 FHBL heterozygotes are usually asymptomatic, but have concentrations of LDL-cholesterol and apoB less than half those in normal subjects, and this has been suggested to provide FHBL subjects with resistance to atherosclerosis and thus lower rates of mortality. In contrast, the index patient's paternal family had a high rate of mortality due to violent suicide. Unlike heterozygous FHBL, homozygous FHBL is characterized by absence, or extremely low levels, of apoB-containing lipoproteins and acanthocytic red blood cells 22 and can manifest clinically in neurological dysfunction, 23 but not always. 24 The index patient was grossly neurologically normal, but had about 17% acanthocytes on blood film, a paranoid psychosis and lower levels of LDL-cholesterol than those previously described in heterozygous FHBL. [24] [25] [26] [27] Heterozygous FHBL subjects, such as the index patient, typically have low plasma concentrations of vitamin E (Table 1) . 28 Vitamin E is essential for neurological function and is transported in plasma in association with the apoB-containing lipoproteins. Low plasma vitamin E has been suggested to play a role in the higher rates of membrane lipid peroxidation found in individuals with schizophrenia and depression when compared to controls. 29, 30 In a study of an individual who had compound heterozygous apoB mutations, apoB-66 plus apoB-25.8, Homer et al. 23 suggested that the clinical presentation, of ataxia, visual impairment and neuropathy, resulted from the inability to transport the active stereoisomer of vitamin E from the liver and that these clinical features were similar to those seen in isolated vitamin E deficiency. Therefore, the index patient's phenotype is intermediate in the spectrum between homozygous FHBL (very low or absent LDL-cholesterol, acanthocytes and sometimes neurological deficit) and other heterozygous FHBL families (no acanthocytes, moderate to low LDL-cholesterol, live longer and have neither functional psychiatric illness nor neurological deficit).
The locus 2p25 has been identified as a putative locus for psychosis in a recent 9 cM genome-wide scan of a large bipolar pedigree sample of 1060 individuals in 154 families. This indicates that genes in this area, such as APOB (2p24), may be important to the development of psychosis, a symptom often linked to suicide and violent behavior. [31] [32] [33] The prevalence of male suicide of all kinds and of all ages in New Zealand was 1 in 6410 in 2002. 34 In contrast, the prevalence of male suicide in the paternal family in three generations was 1 in 3.4, indicating a strong clustering of suicide in this family. The odds ratio for the association between hypocholesterolemia and violent behavior in this family, where cholesterol status was known (n = 8), was 16.9 (95% confidence interval 1.1-239.3). Owing to being deceased, difficulties in tracing some members and the young age of others, insufficient informative family members were available to undertake a gene trait recombination linkage analysis, which would generate an informative lod score. However, 44% of generation II of the paternal family either committed suicide or carried the apoB-29.4 mutation, or both, which is consistent with the autosomal codominant pattern of gene inheritance characteristic of heterozygous FHBL, where 50% of the immediate progeny (generation II) of the index patient's paternal grandfather (I:3) would be expected to have the mutation. However, it remains possible that the apoB 29.4 mutation was not the cause of the observed violent behavior, but is instead in linkage disequilibrium with a causative gene on the same or another chromosome, such as the Y chromosome, as exclusively men are affected in the family. 35 Unfortunately, the pedigree was dominated by male offspring in generation II, making it much more likely that male family members would display the violent behavior trait. In addition, the members of generation III were too young for many to have displayed this trait.
Many clinical trials and meta-analyses support a significant relation between low plasma cholesterol, or lowering cholesterol by diet or medication, and violence and severe irritability. [2] [3] [4] [5] [6] [7] [8] In addition, experimental studies have shown an increase in violent behavior in monkeys assigned to low-cholesterol diets. 36, 37 Human and animal research indicates that low or lowered cholesterol levels may reduce central serotonin activity, which in turn is causally linked to violent behaviors. 4, 38 Therefore, members of a family who inherit hypocholesterolemia might be expected to be prone to violent behavior. However, increased violent behavior in heterozygous FHBL has not been reported before, which suggests that the association between apoB-29.4 and violent behavior is specific to this particular apoB mutation in much the same way that neurological dysfunction is associated with particular homozygous FHBL mutations and not others. 23, 24 The fecundity of members of the index patient's immediate prior paternal generation that carried apoB-29.4 or had committed suicide (II:1, II:4, II:6, II:9) was low, an average of one child each, compared to the remainder (II:2, II:3, II:5, II:7, II:8), an average of two children each. However, the grandfather, an obligate heterozygote for apoB-29.4, had nine children. He committed suicide in his early 40s, which may reflect the moral prohibitions of an earlier age against suicide, whereas those of his children who committed suicide did so in their early 30s. The fecundity of the grandfather could, in one sense, be seen as fortuitous, as the discovery of a large pedigree such as this is unlikely with such a putatively disadvantageous mutation.
In summary, we describe a family with low plasma cholesterol, caused by a novel mutation of apoB (apoB-29.4), where there is an association, with an odds ratio of 16.9, between the hypocholesterolemic status of family members and violent behavior. Therefore, our results add weight to the link between hypocholesterolemia and violent behavior and suggest that the inheritance of a molecular defect of lipoprotein metabolism could predispose individuals to violent behavior.
